The Phase 3 study consisted of 2,400 participants in Asia, Africa, South America and the US. Xocova is also known as ensitrelvir, according to a statement. A once-daily pill, Xocova was approved ...

The oral drug Xocova marks the first home-grown medication, developed by Shionogi & Co., which can be prescribed for patients with mild symptoms, suggesting a stable supply of the tablet will be ...

The name of the pill is Xocova, and its generic name is ensitrelvir ... Patients will be advised to take one tablet a day for five days if the pill is approved. Shionogi requested at the ...

Phase III Scorpio-PEP study results showed Shionogi & Co. Ltd.’s oral antiviral ensitrelvir fumaric acid (Xocova) reduced risk of symptomatic COVID-19 infection in subjects who were exposed to the ...